Undoubtedly correction of depressive disorders is essential in the outcomes of stroke in patients with depression. We should notice that patient with stroke is usually the elderly person burdened with various somatic diseases, with a reduced rate of metabolism of drugs and receives at least three types of medication a day. The lesions of different localization in the depressions with various psychopathological pictures are distributed alm ost evenly. Implementation of Stimuloton combined with non-drug measures is effective in the vast number of stroke patients for controlling the depressive disorders, for improving psychosocial adaptation, and thus for enhance the quality of life.